Sarah Hardy

Director, Head of New Investment

2020 - Current

Chief Investment Officer

2016 - 2020

Archangels is a prominent business angel syndicate, which has been at the forefront of early stage investing in Scotland for more than two decades. It invests in promising start-up and early stage companies across Scotland. Archangels focus on technology and life-sciences companies, and have invested in sectors ranging from software development and alternative energy to biopharmaceuticals and bionics. Our members invest in and mentor promising start-up and early stage companies from Scotland's vibrant technology and life sciences sectors. www.archangelsonline.com

Senior Business Analyst

2006 - 2016

As a Senior Business Development Analyst in Innovations at the Wellcome Trust I identified and cultivated early-stage innovative funding opportunities and project managed a portfolio of healthcare projects. Executed on contract negotiations, due diligence, monitoring patent prosecution and translation strategies leading to commercial exits.

Scienfic Programme Officer

2001 - 2006

Sarah joined the Science Funding Division of the Trust in 2001 and where she worked in a variety of roles. She has had responsibilities to the Physiology and Pharmacology and Neuroscience and Mental Health Funding Committees and was heavily involved in a coordinated £84 million investment to boost the network of centres for experimental medicine (Clinical Research Facilities) in the UK and Eire.

Associate, (secondment)

2012 - 2012

Researcher

1999 - 2000